Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin [4]

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 1, 2001, Pages 144-145

  Wilcox, M H ^a   Fawley, W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM COLONY; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; SCREENING; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0034918846     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus
2. Emergence of vancomycin resistance in Staphylococcus aureus
3. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected U.S. hospitals
4. Staphylococcus aureus with reduced susceptibility to vancomycin, Illinois, 1999